{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:25:52Z","timestamp":1760189152087},"reference-count":38,"publisher":"Wiley","issue":"s3","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":940,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Alcoholism Clin &amp;amp; Exp Res"],"published-print":{"date-parts":[[2005,12]]},"abstract":"<jats:p><jats:bold>A<jats:sc>bstract<\/jats:sc>: <\/jats:bold><jats:bold> Background: <\/jats:bold> The pathogenesis of alcoholic hepatitis (AH) remains unclear and the prognosis of severe alcoholic hepatitis (SAH) is very poor. Deficiency of von Willebrand factor (VWF)\u2010cleaving protease (VWF\u2010CP\/ADAMTS13) results in an increase of the plasma unusually large VWF multimer and leads to platelet clumping, which causes microcirculatory disturbance and finally multiorgan failure. The aim of this study was to explore the potential role of ADAMTS13 on the development of liver disturbance and multiorgan failure in AH.<\/jats:p><jats:p><jats:bold>Methods: <\/jats:bold> The activity of plasma ADAMTS13 and its clinical correlation were determined in 14 patients with AH, 4 with SAH (Maddrey score, mean 62), and 10 with alcoholic liver cirrhosis (LC).<\/jats:p><jats:p><jats:bold>Results: <\/jats:bold> The activity of the plasma ADAMTS13 significantly decreased in patients with AH (mean 59%, <jats:italic>p<\/jats:italic> &lt; 0.001), SAH (17%, <jats:italic>p<\/jats:italic> &lt; 0.001) and LC (76%, <jats:italic>p<\/jats:italic> &lt; 0.02) as compared with the healthy subjects (102%, n = 60). The activity was markedly lower in SAH than in AH (<jats:italic>p<\/jats:italic> &lt; 0.02) and LC (<jats:italic>p<\/jats:italic> &lt; 0.02). In three nonsurvivors with SAH who had multiorgan failure, it was extremely low (4.5%, 5.0%, and 16.0%, respectively), but in a survivor with SAH it remained mild decrease (44%). In AH, the protease activity increased at the recovery stage (42%\u2192 75%, <jats:italic>p<\/jats:italic> &lt; 0.05). In the univariate analysis, the activity correlated with 10 clinical variables including functional liver capacity, inflammation signs, renal function, and platelet count in patients with AH and SAH. Among these, multivariate analysis showed that serum total bilirubin and C\u2010reactive protein independently correlated with the protease activity.<\/jats:p><jats:p><jats:bold>Conclusion: <\/jats:bold> The activity of plasma ADAMTS13 markedly decreased in SAH in addition to AH. The activity was closely related to hyperbilirubinemia and inflammation signs, and was extremely low in nonsurvivors with SAH and multiorgan failure. The marked decrease of plasma ADAMTS13 may, in part, contribute to not only the progression of liver disturbance in AH, but also the development of multiorgan failure in SAH through microcirculatory disturbance.<\/jats:p>","DOI":"10.1097\/01.alc.0000192326.08931.cb","type":"journal-article","created":{"date-parts":[[2010,11,2]],"date-time":"2010-11-02T14:38:57Z","timestamp":1288708737000},"source":"Crossref","is-referenced-by-count":25,"title":["Decreased Activity of Plasma ADAMTS13 May Contribute to the Development of Liver Disturbance and Multiorgan Failure in Patients with Alcoholic Hepatitis"],"prefix":"10.1111","volume":"29","author":[{"given":"Masahito","family":"Uemura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadanobu","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahisa","family":"Toyohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaharu","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Yoshiji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyunichi","family":"Yamao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromichi","family":"Ishizashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80104-4"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-01-0107"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-110-9-685"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840040521"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1999.tb04531.x"},{"key":"e_1_2_1_7_1","first-page":"33S\u201038S","article-title":"Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: Relation to severity of liver diseases","volume":"23","author":"Fujimoto M","year":"2000","journal-title":"Alcohol Clin Exp Res"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02981975"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(91)90933-3"},{"key":"e_1_2_1_10_1","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1182\/blood.V87.10.4223.bloodjournal87104223","article-title":"Partial purification and characterization of protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis","volume":"87","author":"Furlan M","year":"1996","journal-title":"Blood"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.9.3097"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811263392202"},{"key":"e_1_2_1_13_1","first-page":"967","article-title":"Cytokines and hemostasis","volume":"85","author":"Grignani G","year":"2000","journal-title":"Haematologica"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2003.03217.x"},{"key":"e_1_2_1_15_1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/alcalc\/28.Supplement_1B.97","article-title":"Clinical and pathological features, and the mechanism of development in severe alcoholic hepatitis, especially in comparison with acute type fulminant hepatitis","volume":"1","author":"Ishii K","year":"1993","journal-title":"Alcohol"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1998.9458"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/08880010290097288"},{"key":"e_1_2_1_18_1","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1055\/s-0038-1660099","article-title":"Increased factor VIII complex in fulminant hepatic failure","volume":"54","author":"Langley PG","year":"1985","journal-title":"Thromb Haemostasis"},{"issue":"1","key":"e_1_2_1_19_1","first-page":"1938","article-title":"ADAMTS13, the Von Willebrand factor cleaving metalloprotease, is expressed in the perisinusoidal cells of the liver (abstract)","volume":"100","author":"Lee TP","year":"2002","journal-title":"Blood"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(78)90401-8"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.9.2730"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2003.10.009"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112736"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.8.1182"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00100.x"},{"key":"e_1_2_1_26_1","first-page":"21","article-title":"Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease","volume":"24","author":"Moschcowitz E","year":"1924","journal-title":"Proc NY Pathol Sac"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(96)80018-3"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116334"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703544"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-05-1397"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800600817"},{"key":"e_1_2_1_32_1","first-page":"S41","article-title":"von Willebrand factor","volume":"100","author":"Ruggeri ZM","year":"1997","journal-title":"J Clin Invest"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jbchem.a003009"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.2957\/kanzo.34.888"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196603032740901"},{"key":"e_1_2_1_36_1","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1182\/blood.V87.10.4235.bloodjournal87104235","article-title":"Physiological cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion","volume":"87","author":"Tsai H\u2010M","year":"1996","journal-title":"Blood"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811263392203"},{"key":"e_1_2_1_38_1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/alcalc\/28.Supplement_1B.77","article-title":"Studies on capillarization of the hepatic sinusoids in alcoholic liver disease","volume":"28","author":"Urashima S","year":"1993","journal-title":"Alcohol Alcohol"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C100515200"}],"container-title":["Alcoholism: Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1097%2F01.alc.0000192326.08931.cb","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1097\/01.alc.0000192326.08931.cb","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T21:37:04Z","timestamp":1695764224000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1097\/01.alc.0000192326.08931.cb"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":38,"journal-issue":{"issue":"s3","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["10.1097\/01.alc.0000192326.08931.cb"],"URL":"https:\/\/doi.org\/10.1097\/01.alc.0000192326.08931.cb","archive":["Portico"],"relation":{},"ISSN":["0145-6008","1530-0277"],"issn-type":[{"value":"0145-6008","type":"print"},{"value":"1530-0277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}